Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Accelerated Degradation of cFLIP Mediated By Inhibition of Methyltransferases Sensitizes B-Cell Lymphoma Cells to TRAIL-Induced Apoptosis

Frank K Braun, PhD, Rohit Mathur, PhD, Lalit Sehgal, PhD, Rachel Wilkie-Grantham, Joya Chandra, PhD, Zuzana Berkova, PhD, Felipe Samaniego, MD

Blood (2014) 124 (21): 920.

https://doi.org/10.1182/blood.V124.21.920.920

Published: 2014

Journal Articles

Molecular Signatures of Tumor-Initiating Cells Unveil Wnt Pathway As a Therapeutic Target in Mantle Cell Lymphoma

Felipe Samaniego, MD, Lalit Sehgal, PhD, Frank K Braun, PhD, Zuzana Berkova, PhD, Jorge E. Romaguera, MD, Michael Wang, MD, M. Alma Rodriguez, MD, Sattva S Neelapu, MD, Rohit Mathur, PhD

Blood (2014) 124 (21): 2148.

https://doi.org/10.1182/blood.V124.21.2148.2148

Published: 2014

Journal Articles

Human Mesenchymal Stem Cells Promote Resistance to Death Signals By Potentiating FGF Signaling in Mantle Cell Lymphoma

Lalit Sehgal, PhD, Rohit Mathur, PhD, Frank K Braun, PhD, Zuzana Berkova, PhD, Sattva Neelapu, MD, Felipe Samaniego, MD

Blood (2014) 124 (21): 5119.

https://doi.org/10.1182/blood.V124.21.5119.5119

Published: 2014

Journal Articles

Histone 3 Methyltransferase (EZH2) Inhibition Enhances TRAIL-Induced Apoptosis In Mantle Cell Lymphoma Cells By Accelerated cFLIP Degradation

Frank K Braun, PhD, Rohit Mathur, PhD, Lalit Sehgal, Ph.D, Zuzana Berkova, PhD, Felipe Samaniego, M.D., M.P.H

Blood (2013) 122 (21): 4425.

https://doi.org/10.1182/blood.V122.21.4425.4425

Published: 2013

Journal Articles

A Single Center Phase II Trial Of 90 yttrium-Ibritumomab-Tiuxetan Produces High Response Rates As First-Line Therapy For Early Stage B Cell Indolent Lymphoma, Including Bulky Disease

Felipe Samaniego, M.D., M.P.H, Jorge E Romaguera, MD, Nathan Fowler, MD, Michelle A. Fanale, MD, Jatin J. Shah, M.D., Peter McLaughlin, MD, Barbara Pro, MD, Vijairam Selvaraj, MD, Frank K Braun, PhD, Rohit Mathur, PhD, Lei Feng, M.S., Sattva Neelapu, MD, Larry W. Kwak, MD, PhD

Blood (2013) 122 (21): 3039.

https://doi.org/10.1182/blood.V122.21.3039.3039

Published: 2013

Journal Articles

FAS-AS1 Intronic Lncrna and Ibrutinib Negatively Regulate Soluble Fas Production and Sensitize B-Cell Lymphomas To Fas-Mediated Apoptosis

Lalit Sehgal, Ph.D, Frank K Braun, PhD, Rohit Mathur, PhD, Sattva Neelapu, MD, Larry W. Kwak, MD, PhD, Zuzana Berkova, PhD, Felipe Samaniego, M.D., M.P.H

Blood (2013) 122 (21): 5051.

https://doi.org/10.1182/blood.V122.21.5051.5051

Published: 2013

Journal Articles

CD74 Interferes With The Expression Of Fas Receptor On The Cell Surface

Zuzana Berkova, PhD, Xue Ao, MS, Frank K Braun, PhD, Jillian F Wise, B.S., Lalit Sehgal, Ph.D, Felipe Samaniego, M.D., M.P.H

Blood (2013) 122 (21): 4263.

https://doi.org/10.1182/blood.V122.21.4263.4263

Published: 2013

Journal Articles

Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex

Jillian F. Wise, Zuzana Berkova, Rohit Mathur, Haifeng Zhu, Frank K. Braun, Rong-Hua Tao, Anita L. Sabichi, Xue Ao, Hoyoung Maeng, Felipe Samaniego

Blood (2013) 121 (23): 4729–4739.

https://doi.org/10.1182/blood-2012-12-471094

Published: 2013

Includes: Supplemental data

Journal Articles

Mechanism of Regulating Fas Signaling by Promyelocytic Leukemia Protein (PML) and Its Dominant-Negative Mutant PMLRARα

Rong-Hua Tao, M.D., Ph.D., Zuzana Berkova, PhD, Jillian F Wise, B.S., Haifeng Zhu, Ph.D., Xue Ao, MS, Zeming Chen, PhD, Wenzhuo Zhuang, PhD, Frank K Braun, PhD, Rohit Mathur, PhD, Felipe Samaniego, M.D.

Blood (2012) 120 (21): 1327.

https://doi.org/10.1182/blood.V120.21.1327.1327

Published: 2012

Journal Articles

Regulation of Fas-mediated Apoptosis in B-Cell Lymphomas by Nucleolin.

Felipe Samaniego, MD, MPH, Jillian F Wise, BS, Rong-Hua Tao, MD, PhD, Haifeng Zhu, PhD, Xue Ao, MS, Zeming Chen, PhD, Wenzhuo Zhuang, PhD, Frank K Braun, PhD, Rohit Mathur, PhD, Jorge Enrique Romaguera, MD, Luis Fayad, MD, Michael Wang, MD, Peter McLaughlin, MD, Timothy J. McDonnell, MD, PhD, Keyur P. Patel, MD, PhD, Sattva S. Neelapu, MD, Larry W. Kwak, MD, PhD, Zuzana Berkova, PhD

Blood (2012) 120 (21): 2406.

https://doi.org/10.1182/blood.V120.21.2406.2406

Published: 2012

NARROW

Accelerated Degradation of cFLIP Mediated By Inhibition of Methyltransferases Sensitizes B-Cell Lymphoma Cells to TRAIL-Induced Apoptosis

Molecular Signatures of Tumor-Initiating Cells Unveil Wnt Pathway As a Therapeutic Target in Mantle Cell Lymphoma

Human Mesenchymal Stem Cells Promote Resistance to Death Signals By Potentiating FGF Signaling in Mantle Cell Lymphoma

Histone 3 Methyltransferase (EZH2) Inhibition Enhances TRAIL-Induced Apoptosis In Mantle Cell Lymphoma Cells By Accelerated cFLIP Degradation

A Single Center Phase II Trial Of 90 yttrium-Ibritumomab-Tiuxetan Produces High Response Rates As First-Line Therapy For Early Stage B Cell Indolent Lymphoma, Including Bulky Disease

FAS-AS1 Intronic Lncrna and Ibrutinib Negatively Regulate Soluble Fas Production and Sensitize B-Cell Lymphomas To Fas-Mediated Apoptosis

CD74 Interferes With The Expression Of Fas Receptor On The Cell Surface

Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex

Mechanism of Regulating Fas Signaling by Promyelocytic Leukemia Protein (PML) and Its Dominant-Negative Mutant PMLRARα

Regulation of Fas-mediated Apoptosis in B-Cell Lymphomas by Nucleolin.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only